Acute myeloid leukemia with t(9;22)(q34.1;q11.2)

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:585867C92.0
Who is this for?
Show terms as
6Active trials19Specialists8Treatment centers

Where are you in your journey?

ℹ
UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Also known as:

Acute myeloid leukemiaAMLAML with BCR-ABL1AML with t(9;22)(q34.1;q11.2)
Orphanet ↗NORD ↗

FDA & Trial Timeline

7 events
Oct 2021Two Step Haplo With Radiation Conditioning

Thomas Jefferson University — PHASE2

TrialRECRUITING
May 2020Decitabine, Venetoclax, and Ponatinib for the Treatment of Philadelphia Chromosome-Positive Acute Myeloid Leukemia or Myeloid Blast Phase or Accelerated Phase Chronic Myelogenous Leukemia

M.D. Anderson Cancer Center — PHASE2

TrialACTIVE NOT RECRUITING
Jan 2019Hu8F4 in Treating Patients With Advanced Hematologic Malignancies

M.D. Anderson Cancer Center — PHASE1

TrialACTIVE NOT RECRUITING
Oct 2018Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy

M.D. Anderson Cancer Center — PHASE1

TrialRECRUITING
Feb 2018Low-Intensity Chemotherapy, Ponatinib and Blinatumomab in Treating Patients With Philadelphia Chromosome-Positive and/or BCR-ABL Positive Acute Lymphoblastic Leukemia

M.D. Anderson Cancer Center — PHASE2

TrialACTIVE NOT RECRUITING
Aug 2016Busulfan, Fludarabine Phosphate, and Post-Transplant Cyclophosphamide in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant

M.D. Anderson Cancer Center — PHASE2

TrialACTIVE NOT RECRUITING
Oct 2011Combination Chemotherapy and Ponatinib Hydrochloride in Treating Patients With Acute Lymphoblastic Leukemia

M.D. Anderson Cancer Center — PHASE2

TrialACTIVE NOT RECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Acute myeloid leukemia with t(9;22)(q34.1;q11.2).

6 clinical trialsare actively recruiting — trials can provide access to cutting-edge therapies.

View clinical trials →

Clinical Trials

6 recruitingView all trials with filters →
Phase 24 trials
Low-Intensity Chemotherapy, Ponatinib and Blinatumomab in Treating Patients With Philadelphia Chromosome-Positive and/or BCR-ABL Positive Acute Lymphoblastic Leukemia
Phase 2
Active
PI: Elias Jabbour (M.D. Anderson Cancer Center) · Sites: Houston, Texas · Age: 18–99 yrs
View on ClinicalTrials.gov ↗I'm interested →
Decitabine, Venetoclax, and Ponatinib for the Treatment of Philadelphia Chromosome-Positive Acute Myeloid Leukemia or Myeloid Blast Phase or Accelerated Phase Chronic Myelogenous Leukemia
Phase 2
Active
PI: Nicholas Short (M.D. Anderson Cancer Center) · Sites: Houston, Texas · Age: 18–99 yrs
View on ClinicalTrials.gov ↗I'm interested →
Two Step Haplo With Radiation Conditioning
Phase 2
Actively Recruiting
PI: Usama Gergis, MD (Thomas Jefferson University) · Sites: Philadephia, Pennsylvania · Age: 18–99 yrs
View on ClinicalTrials.gov ↗I'm interested →
Busulfan, Fludarabine Phosphate, and Post-Transplant Cyclophosphamide in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant
Phase 2
Active
PI: Uday R Popat, MD (M.D. Anderson Cancer Center) · Sites: Houston, Texas · Age: 12–75 yrs
View on ClinicalTrials.gov ↗I'm interested →
Phase 12 trials
Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy
Phase 1
Actively Recruiting
PI: Maro Ohanian (M.D. Anderson Cancer Center) · Sites: Houston, Texas · Age: 1–99 yrs
View on ClinicalTrials.gov ↗I'm interested →
Hu8F4 in Treating Patients With Advanced Hematologic Malignancies
Phase 1
Active
PI: Tapan M Kadia (M.D. Anderson Cancer Center) · Sites: Augusta, Georgia; The Bronx, New York +2 more · Age: 18–99 yrs
View on ClinicalTrials.gov ↗I'm interested →

Specialists

19 foundView all specialists →
BS
Brenda Sandmaier
SEATTLE, WA
Specialist
PI on 17 active trials
TK
Tapan M Kadia
Houston, Texas
Specialist

Rare Disease Specialist

PI on 9 active trials
EJ
Elias Jabbour
HOUSTON, TX
Specialist
PI on 9 active trials
NJ
Nitin Jain
Specialist
PI on 6 active trials57 Acute myeloid leukemia with t(9;22)(q34.1;q11.2) publications
AM
Amanda Olson, MD
Specialist
PI on 2 active trials
SS
Samer Srour
HOUSTON, TX
Specialist
PI on 2 active trials8 Acute myeloid leukemia with t(9;22)(q34.1;q11.2) publications
UM
Usama Gergis, MD
ALLENTOWN, PA
Specialist
PI on 2 active trials
RM
Ryotaro Nakamura, MD
DUARTE, CA
Specialist
PI on 5 active trials
GG
George Georges
DURHAM, NC
Specialist
PI on 4 active trials
NS
Nicholas Short
Specialist
PI on 4 active trials
IG
Ivana Gojo
BALTIMORE, MD
Specialist
PI on 5 active trials
RO
Richard J. O'Reilly
NEW YORK, NY
Specialist
PI on 1 active trial
RA
Rajni Agarwal-Hashmi
Specialist
PI on 1 active trial
FB
Frank M. Balis
PHILADELPHIA, PA
Specialist
PI on 1 active trial
DS
Danielle A Shafer
FAIRFAX, VA
Specialist
PI on 1 active trial
UP
Uday R Popat
HOUSTON, TX
Specialist
PI on 2 active trials
MO
Maro Ohanian
HOUSTON, TX
Specialist
PI on 3 active trials
MC
Martin Champagne
Specialist
PI on 1 active trial
AM
Akil Merchant
LOS ANGELES, CA
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center ↗

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center ↗

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program ↗

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site ↗

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site ↗

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site ↗

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine ↗

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program ↗

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Acute myeloid leukemia with t(9;22)(q34.1;q11.2).

Search all travel grants →NORD Financial Assistance ↗

Community

Open Acute myeloid leukemia with t(9;22)(q34.1;q11.2)Forum →

No community posts yet. Be the first to share your experience with Acute myeloid leukemia with t(9;22)(q34.1;q11.2).

Start the conversation →

Latest news about Acute myeloid leukemia with t(9;22)(q34.1;q11.2)

Disease timeline:

New recruiting trial: Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy

A new clinical trial is recruiting patients for Acute myeloid leukemia with t(9;22)(q34.1;q11.2)

New recruiting trial: Two Step Haplo With Radiation Conditioning

A new clinical trial is recruiting patients for Acute myeloid leukemia with t(9;22)(q34.1;q11.2)

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Acute myeloid leukemia with t(9;22)(q34.1;q11.2)

Are there clinical trials for Acute myeloid leukemia with t(9;22)(q34.1;q11.2)?

Yes — 6 recruiting clinical trials are currently listed for Acute myeloid leukemia with t(9;22)(q34.1;q11.2) on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.

Which specialists treat Acute myeloid leukemia with t(9;22)(q34.1;q11.2)?

19 specialists and care centers treating Acute myeloid leukemia with t(9;22)(q34.1;q11.2) are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.